Standard
Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab. / Halling, Anne-Sofie; Zachariae, Claus; Thyssen, Jacob P.
In:
Contact Dermatitis, Vol. 83, No. 1, 07.2020, p. 37-38.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Halling, A-S
, Zachariae, C & Thyssen, JP 2020, '
Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab',
Contact Dermatitis, vol. 83, no. 1, pp. 37-38.
https://doi.org/10.1111/cod.13501
APA
Halling, A-S.
, Zachariae, C., & Thyssen, J. P. (2020).
Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.
Contact Dermatitis,
83(1), 37-38.
https://doi.org/10.1111/cod.13501
Vancouver
Halling A-S
, Zachariae C, Thyssen JP.
Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.
Contact Dermatitis. 2020 Jul;83(1):37-38.
https://doi.org/10.1111/cod.13501
Author
Halling, Anne-Sofie ; Zachariae, Claus ; Thyssen, Jacob P. / Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab. In: Contact Dermatitis. 2020 ; Vol. 83, No. 1. pp. 37-38.
Bibtex
@article{dad61d503acc4f55a3fe166d5fabcaf5,
title = "Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab",
author = "Anne-Sofie Halling and Claus Zachariae and Thyssen, {Jacob P}",
year = "2020",
month = jul,
doi = "10.1111/cod.13501",
language = "English",
volume = "83",
pages = "37--38",
journal = "Contact Dermatitis",
issn = "0105-1873",
publisher = "Wiley-Blackwell",
number = "1",
}
RIS
TY - JOUR
T1 - Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab
AU - Halling, Anne-Sofie
AU - Zachariae, Claus
AU - Thyssen, Jacob P
PY - 2020/7
Y1 - 2020/7
U2 - 10.1111/cod.13501
DO - 10.1111/cod.13501
M3 - Journal article
C2 - 32087035
VL - 83
SP - 37
EP - 38
JO - Contact Dermatitis
JF - Contact Dermatitis
SN - 0105-1873
IS - 1
ER -